Trends in Clinical Trial Data

The clinical trial world is experiencing a considerable increase in the quantity of available clinical data. In this video from the June 2014 ClinOps Toolkit meetup event, Marc Desgrousilliers, CTO of Clinovo delves into emerging trends in clinical trial data.  Most importantly, the increasing quantity of patient and clinical trial data (more sources, more complexity,…

Continue Reading →

Six “Easy Wins” to Immediately Improve Clinical Trials Financial Forecasts

Six “Easy Wins” to Immediately Improve Clinical Trials Financial Forecasts As you’re busy trying to initiate sites, manage enrollment, and meet trial targets, those momentum-interrupting party-poopers in Finance demand another financial reforecast; the very same folks who, months later, will demand to know why your forecast numbers were so far off. No one disputes that…

Continue Reading →

Six Strategies to be a More Effective Monitor

Become a More Effective Monitor Six Strategies to be a More Effective Monitor On-Demand Webinar by Patty Kasper, MS, CCRA When I first became a CRA, I took a course led by expert in clinical monitoring, Patty Kasper, MS, CCRA. Today, almost a decade later, I still regularly reference the materials and Patty’s straightforward methods for…

Continue Reading →

Back on my RBM Soapbox

Time for another installment of Nadia’s RBM Soapbox More from Transcelerate this week on the Risk-Based Monitoring (RBM Methodology).  Check out the July update here. As an industry, we absolutely need more conversations about quality, oversight, completeness, and appropriate monitor expectations.  So don’t get me wrong, I love dialogue on this and many other topics.…

Continue Reading →

DIA Recap of Risk Based Monitoring

A Recap from Lorraine Attending DIA 2014 this year was a wonderful privelege but it was impossible to absorb it all. This is my DIA recap. For any given timeslot, up to 10 offerings or conference sessions and various seminars were offered. I downloaded the app on my iPad in advance and that helped me…

Continue Reading →

Clinical Trial Data Quality: Quick View of Our Event

Patient Profiles and Clinovo sponsored the most recent ClinOps Toolkit event on June 11th, 2014: Leveraging Real-Time Clinical Trial Data Reviews.  This free panel discussion in Redwood City featured the following industry experts and their perspective on trends (and challenges!) in data collection and analysis: Moderator Peter St. Wecker, Sr. Clinical Manager at Theravance Speakers…

Continue Reading →

eBook: Clinical Trials Patient Recruiting and Retention (Tips for Success)

eBook: Clinical Trials Patient Recruiting and Retention (Tips for Success) Mosio is offering a free eBook full of tips for clinical trials patient recruiting and retention. The book is a compiled list of tips and advice from a handful of industry veterans from patient recruitment companies, sponsors and CROs, including ClinOps Toolkit’s own Nadia Bracken.…

Continue Reading →

SCOPE 2014 Final Sessions

SCOPE 2014 Final Sessions Previously Posted Day 1, February 4th, 2014 Day 2, AM sessions Day 2, Part 2 Day 3, Plenary Keynotes Clinical Finance Can be Fun? Last week at SCOPE, following the plenary keynotes I headed straight for my good friend, Chris Chan’s session.  A Bay Area buddy and Industry thought-leader, Chris always delivers…

Continue Reading →

Final Keynotes #SCOPE2014

Previously Posted Re-caps Day 1, February 4th, 2014 Day 2, AM sessions Day 2, Part 2 Final Day of SCOPE: Thursday, February 6th, 2014 AM Keynote: Innovation During the plenary keynotes at SCOPE I learned that “current public image ratings of pharma are worse than those of the tobacco industry.” Ouch. Andy Lee of Genzyme…

Continue Reading →

Summary of Day 2 Part 2 #SCOPE2014

Recap of Wednesday Afternoon at SCOPE – February 5th, 2014 Thank you for reading part 2 of the day 2 summary of sessions for Summit for Clinical Operations Executives (SCOPE) conference. Previously Posted Re-caps Day 1, February 4th, 2014 Day 2, AM sessions Couldn’t make it to #SCOPE2014? Check out recap of @Amgen & Quintiles’ talk…

Continue Reading →

Page 2 of 13